Julie Smith - Net Worth and Insider Trading

Over the past 18 months, Julie Smith made no insider transaction in Stoke Therapeutics Inc (STOK). Other recent insider transactions involving Stoke Therapeutics Inc (STOK) include a net sale of 149,116 shares made by Barry Ticho , a net sale of 9,423 shares made by Jonathan Allan , and a net sale of 3,600,000 shares made by Skorpios Trust .

In summary, during the past 3 months, insiders sold 3,650,973 shares of Stoke Therapeutics Inc (STOK) in total and bought 0 shares, with a net sale of 3,650,973 shares. During the past 18 months, 3,777,921 shares of Stoke Therapeutics Inc (STOK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,777,921 shares.

Stoke Therapeutics Inc (STOK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Julie Smith made no insider transaction in Exelixis Inc (EXEL). Other recent insider transactions involving Exelixis Inc (EXEL) include a net sale of 247,500 shares made by Jeffrey Hessekiel , a net sale of 166,722 shares made by Patrick J. Haley , and a net purchase of 190,000 shares made by David Edward Johnson .

In summary, during the past 3 months, insiders sold 66,225 shares of Exelixis Inc (EXEL) in total and bought 190,000 shares, with a net purchase of 123,775 shares. During the past 18 months, 916,236 shares of Exelixis Inc (EXEL) were sold and 310,409 shares were bought by its insiders, resulting in a net sale of 605,827 shares.

Exelixis Inc (EXEL)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Audentes Therapeutics Inc (BOLD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Audentes Therapeutics Inc (BOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Audentes Therapeutics Inc (BOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Raptor Pharmaceutical Corp (RPTP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Raptor Pharmaceutical Corp (RPTP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Raptor Pharmaceutical Corp (RPTP)'s detailed insider trading history can be found in Insider Trading Tracker table.